Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: GlaxoSmithKline (Ireland) Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Ventolin Syrup.
Pharmaceutical Form |
---|
Syrup. A clear, colourless to pale yellow viscous liquid with an odour of orange. |
Each 5 ml contains 2 mg Salbutamol (as Salbutamol Sulfate BP).
Excipient with known effect: Sodium.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Salbutamol |
Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases. |
List of Excipients |
---|
Sodium citrate |
Type III amber glass bottle with plastic, child resistant, pilfer-proof caps with low density polyethylene polyvinylidene chloride low density polyethylene (LDPE-PVDC-LDPE) faced liners.
Pack size: 150 ml.
GlaxoSmithKline (Ireland) Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
19628
Date of first authorisation: 29 April 2004
Date of latest renewal: 17 July 2009
Drug | Countries | |
---|---|---|
VENTOLIN | Australia, Canada, Cyprus, Estonia, Spain, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.